U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

The next transformative phase of weight-loss medication is upon us, with the US Food and Drug Administration (FDA) approving Novo Nordisk's highly anticipated oral GLP-1 drug – with a starting dose ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

This new pill contains the same active ingredient as injectable Wegovy and Ozempic, semaglutide. It is the first GLP-1 pill ...

The FDA’s approval of a GLP-1 weight-loss pill could make these drugs easier to access and harder to ignore. People who are squeamish about needles for administering GLP-1 weight-loss drugs will soon ...

Everyone hoping for a slimmed down 2026 got a boost with the news the US Food and Drug Administration has approved a pill version of the weight-loss drug Wegovy, making it the first in this new era.

The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

The Wegovy pill is FDA-approved to reduce excess body weight and maintain weight reduction long-term in adults who have ...

A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for ...

The clearance brings an oral form of Novo’s Wegovy to market ahead of Lilly’s rival medication and kicks off the next phase ...

In the studies the company submitted to the FDA, people who took the daily Wegovy pill lost about the same amount of ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved once-daily Wegovy (R) pill, the first oral GLP-1 medicine for obesity in the US. (3) Wegovy (R) pill is used ...